Bristol Myers Squibb Co. (BMY)
61.48
-1.52
(-2.41%)
USD |
NYSE |
Oct 23, 16:00
61.49
+0.01
(+0.02%)
Pre-Market: 20:00
Bristol Myers Squibb Market Cap : 125.60B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 125.60B |
| October 22, 2026 | 128.71B |
| October 21, 2026 | 124.87B |
| October 20, 2026 | 126.01B |
| October 19, 2026 | 120.19B |
| October 16, 2026 | 122.07B |
| October 15, 2026 | 123.74B |
| October 14, 2026 | 121.11B |
| October 13, 2026 | 115.78B |
| October 12, 2026 | 117.64B |
| October 09, 2026 | 120.78B |
| October 08, 2026 | 121.72B |
| October 07, 2026 | 121.97B |
| October 06, 2026 | 121.74B |
| October 05, 2026 | 120.15B |
| October 02, 2026 | 124.93B |
| October 01, 2026 | 125.56B |
| September 30, 2026 | 127.48B |
| September 29, 2026 | 128.42B |
| September 28, 2026 | 130.51B |
| September 25, 2026 | 128.42B |
| September 24, 2026 | 125.64B |
| September 23, 2026 | 124.93B |
| September 22, 2026 | 127.18B |
| September 21, 2026 | 127.93B |
| Date | Value |
|---|---|
| September 18, 2026 | 128.83B |
| September 17, 2026 | 128.38B |
| September 16, 2026 | 129.93B |
| September 15, 2026 | 130.20B |
| September 14, 2026 | 130.96B |
| September 11, 2026 | 130.02B |
| September 10, 2026 | 130.24B |
| September 09, 2026 | 131.59B |
| September 08, 2026 | 132.16B |
| September 04, 2026 | 136.51B |
| September 03, 2026 | 139.11B |
| September 02, 2026 | 138.23B |
| September 01, 2026 | 136.72B |
| August 31, 2026 | 136.49B |
| August 28, 2026 | 136.02B |
| August 27, 2026 | 136.78B |
| August 26, 2026 | 138.05B |
| August 25, 2026 | 138.76B |
| August 24, 2026 | 137.45B |
| August 21, 2026 | 136.90B |
| August 20, 2026 | 133.76B |
| August 19, 2026 | 138.13B |
| August 18, 2026 | 134.94B |
| August 17, 2026 | 132.04B |
| August 14, 2026 | 130.40B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
| Merck & Co., Inc. | 358.62B |
| Pfizer Inc. | 171.14B |
| AstraZeneca PLC | 531.90B |
Market Cap Related Metrics
| PE Ratio | 13.54 |
| PS Ratio | 2.554 |
| PEG Ratio | 0.1629 |
| Price to Book Value | 5.628 |
| Price to Free Cash Flow | 10.98 |
| Price | 61.48 |
| Earnings Yield | 7.38% |
| PEGY Ratio | 0.1552 |
| Operating PE Ratio | 7.894 |
| Normalized PE Ratio | 10.01 |